Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Comprehensive Loss

v3.23.1
Consolidated Statements of Comprehensive Loss - GBP (£)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Profit or loss [abstract]      
Revenue £ 3,844,532 £ 1,978,659 £ 1,978,659
Research and development expenses (7,447,507) (6,156,889) (6,679,919)
Administrative expenses (7,013,056) (2,058,844) (2,206,751)
Administrative expenses – costs related to listing (1,305,087) (1,049,950)
Foreign exchange losses (120,974) (82,764)
Other income 6,381 569,200
Total operating expenses, net (15,886,624) (9,342,066) (8,317,470)
Loss on modification of convertible loan (140,344)
Change in fair value of convertible loan derivatives 7,112,034 (4,181,545)
Change in fair value of warrant derivatives 12,785,290
Change in fair value of other derivatives (3,832,379)
Finance income 2,208 33 1,029
Finance costs (6,994,423) (3,438,548) (292,062)
Loss before tax (3,109,706) (14,983,467) (6,629,844)
Income tax credit 1,720,000 1,407,542 1,171,928
Net loss for the year and Total comprehensive loss £ (1,389,706) £ (13,575,925) £ (5,457,916)
Basic and diluted loss per share £ (2.02) £ (34.76) £ (14.42)